Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-07
1999-02-23
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514249, 514250, 540599, 544343, C07D40306, A61K 31495
Patent
active
058744266
ABSTRACT:
A novel series of substituted quinoxaline 2,3-diones of Formula I ##STR1## useful as neuroprotective agents are taught. Novel intermediates, processes of preparation, and pharmaceutical compositions containing the compounds are also taught. The compounds are glutamate antagonists and are useful in the treatment of stroke, cerebral ischemia, or cerebral infarction resulting from thromboembolic or hemorrhagic stroke, cerebral vasospasms, hypoglycemia, cardiac arrest, status epilepticus, perinatal asphyxia, anoxia, seizure disorders, pain, Alzheimer's, Parkinson's, and Huntington's Diseases.
Kornberg Brian Edward
Nikam Sham
Rafferty Michael Francis
Yuen Po-Wai
Anderson Elizabeth M.
Berch Mark L.
Kifle Bruck
Warner-Lambert & Company
LandOfFree
Cyclic amine derivatives of substituted quinoxaline 2,3-diones a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic amine derivatives of substituted quinoxaline 2,3-diones a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic amine derivatives of substituted quinoxaline 2,3-diones a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307137